Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.236
Delayed Data
As of Jul 25
 0.00 / 0.00%
Today’s Change
0.15
Today|||52-Week Range
0.50
-1.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues7.3M3.9M9.6M3.1M
 
 
 
 
 
Depreciation And Amortization7.0K6.0K0.000.00
 
 
 
 
Operating ExpensesGross Income----9.6M--
 
 
General Expenses9.7M6.6M9.7M5.7M
 
 
 
 
 
Research And Development6.5M3.4M7.0M3.5M
 
 
 
 
 
Total Operating Expenses9.7M6.6M9.7M5.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-2.7M-80.0K-2.6M
 
 
 
 
 
Extraordinary Credit4.1M0.000.000.00
 
 
Extraordinary Charge0.00-510.0K0.000.00
 
 
Interest Expense On Debt0.000.000.002.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.7M-3.2M-80.0K-2.6M
 
 
 
 
 
Net Income1.7M-3.2M-80.0K-2.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS61.6M106.6M134.7M135.9M
 
 
 
 
 
Shares To Calculate EPS Diluted72.7M106.6M134.7M135.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.03$0.00-$0.02
 
 
 
 
EPS Diluted$0.02-$0.03-$0.00-$0.02